BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/20/2014 8:36:00 AM | Browse: 908 | Download: 927
 |
Received |
|
2014-04-10 20:05 |
|
Peer-Review Started |
|
2014-04-11 17:10 |
|
To Make the First Decision |
|
2014-04-28 14:30 |
|
Return for Revision |
|
2014-04-30 19:54 |
|
Revised |
|
2014-06-16 00:00 |
|
Second Decision |
|
2014-07-15 14:59 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-07-15 15:14 |
|
Articles in Press |
|
2014-07-15 17:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-11-17 08:48 |
|
Publish the Manuscript Online |
|
2014-11-19 17:43 |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Use of intralesional collagenase in the treatment of peyronie’s disease: A review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Daniel Marchalik, Henry Wright, Frank Hill and Anup Vora |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anup Vora, MD, Department of Urology, 2950 Cleveland Clinic Boulevard, Cleveland Clinic Florida, Cleveland Clinic Blvd, Weston, FL 33331,
United States. anupvora@gmail.com
|
| Key Words |
Peyronie’s disease; Collagenase; Reconstructive urology; Plaque; Intralesional injection |
| Core Tip |
In December of 2013, the United States Food and Drug Administration approved the use of collagenase clostridium histolyticum (CCH) for the treatment of Peyronie’s disease (PD). In all, 5 relevant clinical trials were isolated from 34 results. With limited data on medical PD treatments, the studies to date appear to support CCH as a reasonably safe and well-tolerated non-surgical intervention. However, because no studies compared CCH to other medical interventions and no trials have been conducted to assess the ultimate need for surgical intervention, further comparative investigations are necessary to determine the ultimate role that the intralesional collagenase may play in the treatment of PD.
|
| Publish Date |
2014-11-19 17:43 |
| Citation |
Marchalik D, Wright H, Hill F, Vora A. Use of intralesional collagenase in the treatment of peyronie’s disease: A review. World J Clin Urol 2014; 3(3): 364-369 |
| URL |
http://www.wjgnet.com/2219-2816/full/v3/i3/364.htm |
| DOI |
http://dx.doi.org/10.5410/wjcu.v3.i3.364 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
